Start-up
Immitra Bio GmbH
About Immitra Bio
At Immitra Bio, we are pioneering a novel genetic medicine platform by combining two of the most powerful biomedical technologies: Hematopoietic Stem Cells (HSCs) and CRISPR-Cas9 gene editing. Our innovative approach enables precise and durable gene modifications within blood stem cells, unlocking transformative treatments for rare diseases with high unmet medical needs.
Facts about Immitra Bio
Facts about Immitra Bio
- Founding: 2024
- Focus : Manufacturer
- Industry : Biotechnology
Here you will find Immitra Bio GmbH
Last viewed contents
A new tool to study complex genome interactions - “I was super excited to see that we had uncovered a really strong effect”
When cells are consumed by wanderlust - Whether in fish embryos or human tumors, the same gene controls how cells migrate in cell tissue
Delphi Optics GmbH - Lübeck, Germany
NEXUS Biosystems GmbH - Geretsried, Germany